Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Safety of trastuzumab (Herceptin) during pregnancy: two case reports.

Literature DB >> 20062589

Safety of trastuzumab (Herceptin) during pregnancy: two case reports.

Matthew J Goodyer¹, Jeffri Rm Ismail, Seamus P O'Reilly, Eugene J Moylan, C Anthony M Ryan, Paul Af Hughes, Alan O'Connor.

Abstract

We report on two cases of women on trastuzumab therapy for breast cancer who became pregnant and delivered healthy live infants. At the time of reporting the children are growing and developing normally (ages 3 and 2).

Entities: CellLine Chemical Disease Gene Species

Year: 2009 PMID： 20062589 PMCID： PMC2803989 DOI： 10.1186/1757-1626-2-9329

Source DB: PubMed Journal: Cases J ISSN： 1757-1626

13 in total

Review 1. Placental transport of immunoglobulin G.

Authors: Neil E Simister
Journal: Vaccine Date: 2003-07-28 Impact factor: 3.641

2. Anhydramnios associated with administration of trastuzumab and paclitaxel for metastatic breast cancer during pregnancy.

Authors: Arnim A Bader; Dietmar Schlembach; Karl F Tamussino; Gunda Pristauz; Edgar Petru
Journal: Lancet Oncol Date: 2007-01 Impact factor: 41.316

Review 3. Trastuzumab in pregnancy associated with poor fetal outcome.

Authors: I D Witzel; V Müller; E Harps; F Janicke; M Dewit
Journal: Ann Oncol Date: 2007-12-15 Impact factor: 32.976

4. Case report: evidence for transplacental transfer of maternally administered infliximab to the newborn.

Authors: Eric A Vasiliauskas; Joseph A Church; Neil Silverman; Mary Barry; Stephan R Targan; Marla C Dubinsky
Journal: Clin Gastroenterol Hepatol Date: 2006-10 Impact factor: 11.382

5. Treatment of metastatic breast cancer with trastuzumab and vinorelbine during pregnancy.

Authors: Michelle A Fanale; Anne R Uyei; Richard L Theriault; Karolina Adam; Rachel A Thompson
Journal: Clin Breast Cancer Date: 2005-10 Impact factor: 3.225

6. Herceptin (trastuzumab) therapy during pregnancy: association with reversible anhydramnios.

Authors: William J Watson
Journal: Obstet Gynecol Date: 2005-03 Impact factor: 7.661

7. Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer.

Authors: Martine J Piccart-Gebhart; Marion Procter; Brian Leyland-Jones; Aron Goldhirsch; Michael Untch; Ian Smith; Luca Gianni; Jose Baselga; Richard Bell; Christian Jackisch; David Cameron; Mitch Dowsett; Carlos H Barrios; Günther Steger; Chiun-Shen Huang; Michael Andersson; Moshe Inbar; Mikhail Lichinitser; István Láng; Ulrike Nitz; Hiroji Iwata; Christoph Thomssen; Caroline Lohrisch; Thomas M Suter; Josef Rüschoff; Tamás Suto; Victoria Greatorex; Carol Ward; Carolyn Straehle; Eleanor McFadden; M Stella Dolci; Richard D Gelber
Journal: N Engl J Med Date: 2005-10-20 Impact factor: 91.245

Review 8. Favorable pregnancy outcome following Trastuzumab (Herceptin) use during pregnancy--Case report and updated literature review.

Authors: Alon Shrim; Facundo Garcia-Bournissen; Cynthia Maxwell; Dan Farine; Gideon Koren
Journal: Reprod Toxicol Date: 2007-02-25 Impact factor: 3.143

9. Trastuzumab use for metastatic breast cancer in pregnancy.

Authors: Renuka Sekar; Peter R Stone
Journal: Obstet Gynecol Date: 2007-08 Impact factor: 7.661

7 in total

1. Challenges in managing breast cancer during pregnancy.

Authors: Flora Zagouri; Theodora Psaltopoulou; Constantine Dimitrakakis; Rupert Bartsch; Meletios-Athanassios Dimopoulos
Journal: J Thorac Dis Date: 2013-06 Impact factor: 2.895

2. Is chemotherapy always required for cancer in pregnancy? An observational study.

Authors: E M Walsh; G M O'Kane; K A Cadoo; D M Graham; G J Korpanty; D G Power; D N Carney
Journal: Ir J Med Sci Date: 2017-05-05 Impact factor: 1.568

Review 3. Current approaches in the clinical management of pregnancy-associated breast cancer-pros and cons.

Authors: Pavol Zubor; Peter Kubatka; Ivana Kapustova; Lence Miloseva; Zuzana Dankova; Alexandra Gondova; Tibor Bielik; Stefan Krivus; Jan Bujnak; Zuzana Laucekova; Christina Kehrer; Erik Kudela; Jan Danko
Journal: EPMA J Date: 2018-06-24 Impact factor: 6.543

4. Use of trastuzumab in treating breast cancer during pregnancy: a systematic review and meta-analysis.

Authors: Lin-Yu Xia; Qing-Lin Hu; Qing Zhou
Journal: BMC Womens Health Date: 2021-04-21 Impact factor: 2.809

Review 5. Breast cancer and pregnancy: current concepts in diagnosis and treatment.

Authors: Jennifer K Litton; Richard L Theriault
Journal: Oncologist Date: 2010-12-08

6. Pharmacokinetic Comparability of a Biosimilar Trastuzumab Anticipated from Its Physicochemical and Biological Characterization.

Authors: Mariana P Miranda-Hernández; Carlos A López-Morales; Nelly Piña-Lara; Francisco C Perdomo-Abúndez; Néstor O Pérez; Jorge Revilla-Beltri; Aarón Molina-Pérez; Larisa Estrada-Marín; Luis F Flores-Ortiz; Alejandro Ruiz-Argüelles; Emilio Medina-Rivero
Journal: Biomed Res Int Date: 2015-11-19 Impact factor: 3.411

7. Trastuzumab administration during pregnancy: an update.

Authors: Angeliki Andrikopoulou; Kleoniki Apostolidou; Spyridoula Chatzinikolaou; Garyfalia Bletsa; Eleni Zografos; Meletios-Athanasios Dimopoulos; Flora Zagouri
Journal: BMC Cancer Date: 2021-04-26 Impact factor: 4.430

7 in total